Business Wire

FOURKITES

22.11.2021 10:02:08 CET | Business Wire | Press release

Share
New Research from FourKites and Reuters Highlights Massive Challenges Facing European Supply Chains

To better understand the state of European supply chains, FourKites® , the #1 real-time supply chain visibility platform, partnered with Reuters Events to survey over 450 supply chain leaders across the continent, with particular emphasis on the United Kingdom, Germany and the Netherlands. The responses represent a broad perspective of the concerns and challenges surrounding European supply chains, sustainability and the role of real-time visibility in streamlining operations.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211122005011/en/

Coming in the midst of ongoing disruptions caused by COVID-19, State of the European Supply Chain: Logistics, Sustainability and Visibility Report 2022 reveals that the demand shock, labour shortages, port disruptions and capacity constraints have accelerated the adoption of supply chain visibility solutions throughout Europe. However, while many companies have adopted new digital practices, more than 60% of European companies admitted they’re slow to react to changing trends in logistics technologies, according to the report.

Key findings include:

  • Over half of all respondents are currently using supply chain visibility solutions, but one-third (33%) are having trouble improving data-driven processes such as forecasting, receiving operations and labour.
  • The majority of respondents (67%) cited end-to-end freight traceability as their biggest pain point when transporting goods.
  • More than half of respondents (63%) cited carriers providing inaccurate ETAs as a persistent problem.

“If we have visibility, we can be efficient and flexible," said Ferenc Polgar, Global Distribution Operational Excellence Lead at Bayer. "We can communicate delays to our customers so they can adjust their operations and improve their experience. We can be more effective during peak distribution periods to make sure plans are going accordingly.”

“Being able to see your goods in transit is one piece of the puzzle, but it doesn’t help navigate the many disruptions and delays that inevitably take place once the product leaves the ship or warehouse,” said Matt Elenjickal, founder and CEO of FourKites. “For that reason, the paradigm is shifting to full end-to-end supply chain visibility, wherein the goal is total predictive visibility across the entire supply chain, enabling proactive risk management vs. reactive problem-solving.”

Pain points vary between the UK, Germany and the Netherlands

Looking at their three biggest pain points in transporting goods, respondents from the UK, Germany and the Netherlands had surprisingly different answers:

  • The UK was relatively balanced, with 71% of respondents citing end-to-end freight traceability, carrier relationships, and dwell times as their biggest pain points.
  • In the Netherlands, 75% of retailers and manufacturers said their biggest pain point was carrier relationships.
  • In Germany, 100% of respondents were struggling with ensuring end-to-end freight traceability.

Overall, respondents indicated supply chain visibility improved their planning and inventory management (60%), customer service (56%) and increased efficiency (38%). In the Netherlands, 40% saw an improvement to customer service whereas in Germany that number was even higher at 100%. Meanwhile, in the UK 63% said that improved planning and inventory management is the primary benefit of visibility.

Even the most commonly used mode of transportation also varied widely across the continent: 63% of UK respondents cited full truckload as their key mode of freight, while 80% of Netherlands respondents are using less than truckload, and 100% of German respondents are transporting freight by air, both domestically and internationally.

Sustainability is a priority, but not without challenges

The survey illustrates that sustainability is top of mind for today’s supply chain leaders. Over 80% indicated that they were either holding steady (44%) or increasing (40%) their commitment to sustainability, emphasising the urgency with which businesses understand they are required to act.

The two key supply chain sustainability goals articulated by respondents were the reduction of carbon emissions in transportation (39%) and manufacturing (31%), as well as the reduction of non-renewable packaging materials (31%). However, over a quarter of respondents also reported mapping sustainability impact throughout their supply chain as a challenge to modernising transportation assets.

"We use supply chain visibility data to understand better where there's waste within the supply chain. Where do we have excessive empty miles?" said Paul Avampato, Head of International Logistics at Henkel. "We believe by reducing dwell time that we can keep the network moving smoother. The more we reduce dwell time, the less trucks that you have to put on the road."

Read the full report here .

About FourKites

FourKites® is the #1 supply chain visibility platform in the world, extending visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 2 million shipments daily across road, rail, ocean, air, parcel and courier, and reaching 176 countries, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 750 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/ .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye